Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.25 GBX | +18.46% | +16.67% | +24.19% |
Jun. 14 | Renalytix's Diabetes, Kidney Disease Test Gets Medicare Final Coverage Determination | MT |
Jun. 14 | Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.19% | 37.69M | |
-50.54% | 2.44B | |
+25.26% | 1.98B | |
-8.81% | 1.52B | |
+28.12% | 1.3B | |
-18.54% | 937M | |
-1.69% | 760M | |
-32.14% | 775M | |
-26.54% | 615M | |
+19.34% | 573M |
- Stock Market
- Equities
- RENX Stock
- News Renalytix Plc
- Renalytix Plans to Sell American Depositary Shares for Up to $15 Million